Dutch Pandemic-Related Sales Boost Peaks In 2021, Pharmacy Rout Continues
Executive Summary
The Netherlands' OTC market stabilizes in 2021, after defying the negative impacts of COVID-19 seen in other major European markets the year before. Consumers continued to flock to drugstores and supermarkets rather than pharmacies, highlighting the ongoing structural transformation of the country's consumer health market.
You may also be interested in...
Dutch Parliament To Decide Future Of OTC Market
In January, the Dutch Parliament will debate an amendment to the country's medicines legislation that proposes to remove the requirement for a druggist or assistant druggist to be physically present during the sale of self-care medicines. The move will once again allow supermarkets to sell UAD medicines, with the help of digital tablets offering professional advice, hastening the transformation of the Dutch OTC market, according to Neprofarm's Bernard Mauritz.
COVID VMS Boom Driving Shift To Self-Care As The Netherlands Bucks 2020 Sales Trends
Despite the pandemic, the Dutch OTC market recorded impressive growth of 4.6% in 2020. HBW Insight speaks to Bernard Mauritz, director of the Netherlands' self-care industry association, Neprofarm, about how the country bucked negative sales trends seen in other European OTC markets.
As Botanicals Deadlock Holds Back Investment, Dutch Industry Takes The Initiative
Dutch self-care industry association, Neprofarm, has updated the way it self-regulates botanical health claims in an effort to rebuild confidence in the country's herbal food supplements market.